/
HOFBF
$0.17+$0.01 (+7.48%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.17 – $0.17
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-0.16
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $60.7M | $67.8M | $69.3M | $87.6M | $120.4M | $194.9M | $257.4M | $254.3M |
| Cost of revenue | $48.4M | $59.6M | $39.5M | $64.5M | $91.9M | $150.7M | $169.6M | $286.7M |
| Gross profit | $12.4M | $8.2M | $29.7M | $23.1M | $28.5M | $44.2M | $87.9M | −$32.5M |
| Gross margin | 20.4% | 12.1% | 42.9% | 26.4% | 23.7% | 22.7% | 34.1% | -12.8% |
| R&D | $2.4M | $131.0K | $7.6M | $12.5M | $13.6M | $11.0M | $0 | $0 |
| Operating income | −$77.7M | −$79.6M | −$92.0M | −$118.6M | −$128.6M | −$102.5M | −$113.2M | −$112.6M |
| EBITDA | −$58.5M | −$55.5M | −$69.1M | −$87.7M | −$97.0M | −$62.7M | −$67.9M | −$73.2M |
| Net income | −$84.8M | −$89.2M | −$102.1M | −$126.5M | −$137.4M | −$106.7M | −$123.4M | −$134.8M |
| Net margin | -139.6% | -131.6% | -147.4% | -144.3% | -114.1% | -54.7% | -47.9% | -53.0% |
| EPS (diluted) | -0.33 | -0.29 | -0.31 | -0.35 | -0.37 | -0.27 | -0.30 | -0.33 |
Annual figures · source: Financial Modeling Prep
Peer comparison
HOFSETH BIOCARE ASA
HOFSETH BIOCARE ASA
Held by traders on TradeandTell
No one on the platform currently holds HOFBF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HOFBF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded HOFBF yet.